drugset / Trial / NCT07479602

Intranasal Dexmedetomidine-esketamine Administration and Postoperative Pain in Pediatric Patients

NCT07479602

Phase 4 Recruiting 160 enrolled Peking University First Hospital
RandomizedParallel-groupQuadruple-blindPrevention

Summary

Postoperative pain after adenoid and tonsil surgery is significant, with approximately 75% of pediatric patients experiencing severe postoperative pain. Currently, there is a lack of clinical strategies to safely and effectively manage postoperative pain in children undergoing adenoid and tonsil surgery. Dexmedetomidine and esketamine can achieve appropriate sedation levels and alleviate postoperative pain when used in children. Both drugs can be administered intranasally, and their pharmacological effects complement each other, reducing side effects. This study aims to investigate whether intranasal administration of dexmedetomidine-esketamine combination can improve postoperative analgesia in children undergoing adenoid and tonsil surgery.

Timeline

Start
2026-04-07
Primary completion
2027-02
Completion
2027-02

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified Intranasal
Subject Esketamine Other / unclassified Intranasal

Indications

No indication recorded.